TABLE 4.
Location of malaria testing and drug consumption, pooled over study arm and the baseline, 12-month and 18-month follow-up waves in Western Kenya 2015–2017.
| No test | Tested at CHW | Tested at private | Tested at public | ||||
|---|---|---|---|---|---|---|---|
| Negative | Positive | Negative | Positive | Negative | Positive | ||
| Observations | 3064 | 85 | 301 | 40 | 597 | 259 | 1255 |
| Take AL? | 1959 (68.3) | 35 (43.8) | 294 (98.0) | 16 (40.0) | 457 (76.9) | 118 (45.7) | 1135 (90.7) |
| Drug Combinations | |||||||
| ACTs with Antibiotics n (%) | 399 (13.9) | 8 (10.0) | 16 (5.3) | 12 (30.0) | 186 (31.3) | 71 (27.5) | 418 (33.4) |
| ACTs, No Antibiotics n (%) | 1595 (55.6) | 27 (33.8) | 278 (92.7) | 4 (10.0) | 310 (52.2) | 50 (19.4) | 737 (58.9) |
| Antibiotics, No ACTs n (%) | 271 (9.4) | 26 (32.5) | 0 (0.0) | 12 (30.0) | 39 (6.6) | 107 (41.5) | 50 (4.0) |
| Neither ACT nor Antibiotics n (%) | 604 (21.1) | 19 (23.8) | 6 (2.0) | 12 (30.0) | 59 (9.9) | 30 (11.6) | 47 (3.8) |
| Total Drug Types Taken (SD) | 1.70 (0.75) | 1.51 (0.78) | 1.95 (0.37) | 1.75 (1.10) | 2.11 (0.79) | 1.99 (0.86)ET | 2.27 (0.78) |
| Antibiotics (n, %) | 670 (23.4) | 34 (42.5) | 16 (5.3) | 24 (60.0) | 225 (37.9) | 178 (69.0) | 468 (37.4) |
| Analgesics (n, %) | 2555 (89.1) | 67 (83.8) | 278 (92.7) | 33 (82.5) | 512 (86.2) | 232 (89.9) | 1140 (91.1) |
| ACT (n, %) | 1994 (69.5) | 35 (43.8) | 294 (98.0) | 16 (40.0) | 496 (83.5) | 121 (46.9) | 1155 (92.3) |
| Non-ACT antimalarial | 210 (7.3) | 1 (1.2) | 7 (2.3) | 1 (2.5) | 110 (18.5) | 20 (7.8) | 267 (21.3) |